Temple Health’s implementation of a revolutionary new tool for diabetes management, the EndoTool Sub-Q (SQ) predictive software system, was featured in a Becker’s Hospital Review article. The tool uses algorithms to model, predict and adapt subcutaneous insulin dosing recommendations for each patient. This makes dosing more accurate and allows for more individualized care. The Q&A with Becker’s featured insight from:
• Chaudron Carter Short, PhD, EdD, MHA, MHEd, MSN, RN, NEA-BC, Temple Health’s Executive Vice President and Chief Nurse Executive
• Carl Sirio, MD, Temple Health’s Chief Medical Officer
• Benjamin Slovis, MD, Temple University Hospital’s Chief Medical Information Officer
• Joy Weaver, DNP, MSN, RN-BC, Senior Clinical Performance Excellence Manager
• David Fleece, MD, Professor of Clinical Pediatrics at the Lewis Katz School of Medicine at Temple University